Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lifeward Ltd LFWD

ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive... see more

Recent & Breaking News (NDAQ:LFWD)

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

GlobeNewswire April 1, 2024

VA STAND Act introduced in the United States Senate

GlobeNewswire March 22, 2024

Lifeward Announces Reverse Share Split

GlobeNewswire March 13, 2024

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

GlobeNewswire March 8, 2024

Lifeward announces the Centers for Medicare & Medicaid Services ("CMS") is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered

GlobeNewswire March 1, 2024

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 27, 2024

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

GlobeNewswire February 20, 2024

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

GlobeNewswire January 29, 2024

ReWalk Robotics Expands Direct Sales Coverage to Canada

GlobeNewswire January 12, 2024

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

GlobeNewswire January 11, 2024

First ReWalk Personal Exoskeleton Claim Paid by Medicare

GlobeNewswire January 5, 2024

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities

GlobeNewswire January 4, 2024

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

GlobeNewswire November 30, 2023

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

GlobeNewswire November 28, 2023

ReWalk Robotics Reports Third Quarter 2023 Financial Results

GlobeNewswire November 14, 2023

New Bill Facilitates Veteran Access to Powered Exoskeletons

GlobeNewswire November 10, 2023

ReWalk Robotics to Discuss Medicare's Preliminary Payment Determination for ReWalk Personal Exoskeleton

GlobeNewswire November 7, 2023

ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

GlobeNewswire November 7, 2023

In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton

GlobeNewswire November 6, 2023

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

GlobeNewswire November 2, 2023